As the only industry-led meeting dedicated to preclinical and translational targeted oncology modeling, driven by case studies, enabling our audience to make informed clinical decisions – this is your must attend event in 2022.

With 2022 being free to attend for drug developers and academics, now is your chance to gain exclusive insights, benchmark against your peers and shake hands with thought-leaders! In collaboration with Sanofi, Merck, Amgen, Dana Farber Sanofi, this is the only case studies driven meeting dedicated to in vivo, in vitro experts to enhance their modeling techniques.